# FDA recall D-1077-2018

> **Lupin Pharmaceuticals Inc.** · Class II · drug recall initiated 2018-08-13.

## Product

Lisinopril Tablets USP, 10mg, 1000-count bottles, Rx only, Manufactured for: Lupin Pharmaceuticals Inc. Baltimore, Maryland 21202, NDC 68180-980-03

## Reason for recall

Presence of Foreign Substance: Product complaint was received of metal contaminant observed in one tablet.

## Distribution

Product was distributed to distributors, mail order pharmacy and supermarkets throughout the United States.

## Key facts

- **Recall number:** D-1077-2018
- **Recalling firm:** Lupin Pharmaceuticals Inc.
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2018-08-13
- **Report date:** 2018-08-22
- **Termination date:** 2019-10-15

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Baltimore, MD, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1077-2018

## Citation

> AI Analytics. FDA recall D-1077-2018. Retrieved 2026-06-08 from https://api.ai-analytics.org/recall/D-1077-2018. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*